BOULDER, Colo.--(BUSINESS WIRE)-- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the third quarter of fiscal 2010 on Monday, May 3, 2010, and will hold a conference call on Tuesday, May 4, 2010 at 9:00 a.m. Eastern Time to discuss these results. Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.
|
Conference Call Information |
||
|
Date: |
Tuesday, May 4, 2010 | |
|
Time: |
9:00 a.m. Eastern Time | |
|
Toll-Free: |
888-437-9315 | |
|
Toll: |
719-325-2138 | |
|
Pass Code: |
1485835 | |
|
Webcast: |
||
A replay of the call will be available as a webcast on www.arraybiopharma.com and by phone for one week by dialing toll-free (888) 203-1112 or (719) 457-0820. The access code is 1485835.
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small-molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. For more information on Array, please go to www.arraybiopharma.com.
CONTACT:
Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
[email protected]
KEYWORDS: United States North America Colorado
INDUSTRY KEYWORDS: Health Biotechnology Pharmaceutical
MEDIA:
| Logo |